Clinical Research Directory
Browse clinical research sites, groups, and studies.
Amyloid-β Clearance Mechanisms in Alzheimer's Disease
Sponsor: Ludwig-Maximilians - University of Munich
Summary
The focus of this study is to examine the protein-plaque clearance (Aß) in relation to the blood-brain-barrier, the glymphatic system, brain lymphatic system and enzymatic degradation. In order to achieve this aim the investigators intend to study participants with a Subjective Cognitive Decline, Mild Cognitive Impairment and a mild Alzheimer's disease.
Official title: Amyloid-β Clearance Mechanisms: A Multi-modal Study on Lymphatic, Glymphatic and Blood-brain-barrier Function in Alzheimer's Disease
Key Details
Gender
All
Age Range
50 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2021-06-01
Completion Date
2025-10
Last Updated
2025-07-04
Healthy Volunteers
No
Conditions
Interventions
positron emission tomography (PET)
18-Flutemetamol PET (clinical indicated) is going to be performed at the visit.
Locations (1)
Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums
München, Bavaria, Germany